Ilumya (Tildrakizumab-Asmn)
Ilumya is used to treat moderate to severe Plaque psoriasis. Ilumya belongs to a class of drugs known as monoclonal antibodies. The medication is provided as an injection that works within the body to balance an overreactive immune system. Ilumya can lessen the symptoms of plaque psoriasis, including red, scaly, itchy patches of skin.
Indication:
Plaque Psoriasis
Infusion Duration:
Frequency:
Loading Dose: Injections at 0,4 weeks
Maintenance Dose: Every 12 weeks.